Background
==========

Klatskin tumor (hilar cholangiocarcinoma or central bile duct carcinoma, KCC) is a rare type of tumor, with an annual incidence of no more than 1: 100 000 \[[@b1-medscimonit-25-4503]\]. It originates from the bifurcation of the extrahepatic bile duct and was first described in 1965 by Gerald Klatskin who reported 15 cases and defined some features in these cholangiocarcinomas \[[@b2-medscimonit-25-4503]--[@b4-medscimonit-25-4503]\]. Most KCCs are adenocarcinomas with poor differentiation degree, spreading along the duct and nerve sheath \[[@b5-medscimonit-25-4503]\]. There are some risk factors, including primary sclerosing cholangitis (PSC), liver fluke infection (C. sinensis and Opisthorchis viverrini), and intrahepatic bile duct stones, but most KCCs are sporadic with no obvious predisposing factors \[[@b6-medscimonit-25-4503]\]. The symptoms are usually fatigue, jaundice, and cachexia, indicating metastatic or advanced tumors. Most patients have biliary symptoms, including painless jaundice. About 10% of patients also simultaneously present with cholangitis \[[@b7-medscimonit-25-4503]\].

The only curative treatment is a complete surgical resection with histologically negative margins. Current surgical strategies usually include choledochectomy, extended hepatectomy, and portal resection. Due to the local anatomy, the proximal and lateral safety margin R0 resection is a surgery that demands excellent technique \[[@b5-medscimonit-25-4503]\]. Molina et al. reported that lymph node involvement and metastasis were important prognostic factors. The median survival of inoperable patients is 6 to 12 months, and the most common causes of death are liver failure and septic complications \[[@b8-medscimonit-25-4503]\].

To investigate KCC was quite difficult in the past because of its rarity in the general population. The present study gives new insights into KCC by using population data in the Surveillance, Epidemiology, and End Results (SEER) database. The aim of our study was to analyze a large sample and to compare the data between patients with KCC and those with other kinds of cholangiocarcinomas (OCC) to clarify the epidemiologic characteristics, frequency, and survival rates patients with this rare malignant tumor.

Material and Methods
====================

We used SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (1973--2014 varying) to conduct the analysis, which contained patient information from 18 cancer registries. Institutional review board (IRB) approval was not needed because no patient identifiers were used. To obtain the necessary data, International Classification of Diseases and Oncology, third edition (ICD-O-3), codes was used. We used histology codes (8162/3) to obtain the KCC data. We also used topography codes corresponding to the bile biliary tract (22.1, 24.0, 24.1, 24.8, and 24.9) to obtain OCC except for KCC and made a comparison. We excluded patients whose first tumor was not biliary duct-derived, and patients for whom the tumor was not histologically confirmed. We report 2000--2014 incidence data (per 100 000 people) adjusted to the standard 2000 population US Census. Cancer-specific survival (CSS) and overall survival (OS) were selected as the endpoints.

Statistical analysis
--------------------

We used Surveillance Research Program, National Cancer Institute SEER\*Stat software (*[www.seer.cancer.gov/seerstat](www.seer.cancer.gov/seerstat)*) version 8.3.4 to conduct frequency analysis and extract data, as well as to determine the incidence annual percentage change based on 1-year end-points. Continuous data are shown as means and standard deviations and were compared using the *t* test. We used frequencies and percentages to display the categorical variables and compared them using the chi-square test or Fisher's exact test. Kaplan-Meier method with log-rank test was used to conduct survival analysis. Univariate and multivariate Cox regression were conducted to identify the prognostic indicators for KCC. We conducted propensity score 1-to-1 matching to decrease the selection bias and mimic the randomized controlled trials. We divided patients into a KCC group and an OCC group, and baseline characteristics were entered into the logistic model using nearest-neighbor matching with a stringent caliper of 0.05 \[[@b9-medscimonit-25-4503]\]. After we generated the matched datasets, we used them to compare the survival difference between KCC and OCC patients. We used SPSS, version 24.0 (SPSS Inc., Chicago, IL) to conduct the analysis, and 2-sided P\<0.05 was considered statistically significant.

Results
=======

Demographics
------------

In total, 26 137 patients diagnosed with cholangiocarcinomas between 1973 and 2014 were extracted from the SEER database. Among them, 1341 cases were diagnosed with KCC and 24 796 cases were diagnosed with OCC ([Table 1](#t1-medscimonit-25-4503){ref-type="table"}). The number of diagnoses has gradually increased in recent years for both Klatskin tumor and other cholangiocarcinomas (P\<0.001). Males constituted 51.2% of KCC cases and 51.5% of OCC cases, and most patients in both groups were white. Most of the patients in both groups had undergone surgeries (73.4% for KCC and 67.3% for OCC). There was no significant difference in age distribution between the 2 groups of patients (P=0.095), but the difference in survival time was obvious (P\<0.001).

Tumor characteristics and incidence trends
------------------------------------------

As shown in [Table 2](#t2-medscimonit-25-4503){ref-type="table"}, there were significant differences between KCC and OCC groups in pathology grades (P\<0.001), T stage (P=0.040), N stage (P\<0.001), M stage (P\<0.001), and SEER historic stage (P\<0.001). There was no obvious difference in tumor size. Between 2000 and 2014, the overall incidence rate trend of KCC was decreasing and the trend for OCC was increasing ([Figure 1](#f1-medscimonit-25-4503){ref-type="fig"}). The annual percent change (APC) for KCC was −2.962 (P=0.001) and 3.688 for OCC (P\<0.001).

Survival analysis
-----------------

In the original groups, as shown in [Figure 2A, 2B](#f2-medscimonit-25-4503){ref-type="fig"}, the CSS and OS for the OCC group were significantly better than for the KCC group (P\<0.001) and the 1-, 3-, and 5-year CSS rates were higher in OCC patients ([Table 3](#t3-medscimonit-25-4503){ref-type="table"}). Then, we stratified patient survival using the 6^th^ AJCC staging system. [Figure 3](#f3-medscimonit-25-4503){ref-type="fig"} and [Table 3](#t3-medscimonit-25-4503){ref-type="table"} show that the 6^th^ AJCC staging system performs well in classifying OCC patient survival, but did not perform well in KCC patients. Considering the significant differences of baseline characteristics between the KCC and OCC groups, we conducted 1-to-1 propensity score matching; 1046 patients were selected into a matched group and all baseline characteristics were well matched for further analysis ([Table 4](#t4-medscimonit-25-4503){ref-type="table"}). We used the matched group to compare survival between the KCC and OCC groups. As shown in [Figure 2C, 2D](#f2-medscimonit-25-4503){ref-type="fig"}, the OCC group had better survival than the KCC group (P\<0.001).

Finally, we used the original cohort to conduct univariate and multivariate Cox analysis. Gender, year of diagnosis, age, race, pathology grades, and T, N, and M stage were entered into analysis. As shown in [Table 5](#t5-medscimonit-25-4503){ref-type="table"}, age, M stage, and pathology grades were brought into the final model. Older age, higher M stages, and higher pathology grades were associated with worse prognosis for KCC patients.

Discussion
==========

Cholangiocarcinoma is a malignant tumor of epithelial cells, originating from different locations in the biliary tree, and shows markers of biliary cell differentiation. Cholangiocarcinoma is classified according to anatomical location, including intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, and distal cholangiocarcinoma. About 50% of cholangiocarcinomas are perihilar cholangiocarcinoma, 40% of cholangiocarcinomas are distal cholangiocarcinoma, and less than 10% of cholangiocarcinomas are intrahepatic cholangiocarcinoma \[[@b10-medscimonit-25-4503]\]. The perihilar cholangiocarcinoma is also called Klatskin tumor. Due to its rarity, there has been little progress in many research aspects of Klatskin tumor. Therefore, we conducted the present study using the SEER database to resolve this problem.

Klatskin tumor is an advanced disease that usually occurs in patients over age 60 years, which is similar to our results (median age: 71 years) \[[@b11-medscimonit-25-4503]\]. Males and females were affected roughly equally in our study, but some studies have shown that males have a slightly higher incidence. Globally, the highest incidence of Klatskin tumor is in Southeast Asia, and the disease is rare in the United States \[[@b12-medscimonit-25-4503]\].

The cause of Klatskin tumor is still unclear, but many risk factors have been identified. Infection seems to be closely related to the development of cholangiocarcinoma in Asian countries. Liver flukes, including *Clonorchis* trematode and Thai liver fluke, can chronically infect the bile duct and cause the development of cholangiocarcinoma \[[@b13-medscimonit-25-4503]\]. Other risk factors related to Klatskin tumor include alcoholism, hepatitis B and hepatitis C viruses, chronic pancreatitis, primary sclerosing cholangitis, choledochal cysts, and cholelithiasis \[[@b14-medscimonit-25-4503]\].

Current unresectable disease criteria include major portal vein involvement or encapsulation, bilateral spread, bilateral hepatic artery involvement, unilateral liver arterial involvement, and the presence of distant lymph nodes or organ metastases \[[@b15-medscimonit-25-4503]\]. For patients whose tumors are operable, the current primary treatment is surgery. Several studies have shown that patients undergoing resection have significantly longer survival than in non-surgical patients, and the overall 5-year survival rate for highly selected patients is close to 53%.

The resection for Klatskin tumor involves achieving an R0 surgical margin and then trying to improve the survival time. A number of studies have shown that, compared with R1 resection, the overall survival rate of the R0 surgical margin increased significantly \[[@b16-medscimonit-25-4503]\].

There are also some other surgical factors and tumor features related to longer survival time after surgery. Studies showed that the presence of lymph node metastasis was associated with poor survival \[[@b17-medscimonit-25-4503],[@b18-medscimonit-25-4503]\]. Some case analyses showed that elevated preoperative serum bilirubin, histological tumor type, and tumor differentiation in patients are associated with lower survival rates, although these findings vary from study to study \[[@b19-medscimonit-25-4503]--[@b21-medscimonit-25-4503]\]. In our analysis, older age, higher M stages, and higher pathology grades were related to the worse prognosis.

To the best of our knowledge, this is the first study to investigate the clinical characteristics of KCC and identify the difference between KCC and OCC. Although we used the SEER database, which contains massive patient data, there are still several deficiencies. It cannot provide the risk factors related to the KCC, and the surgical margin status is not available. Also, the recurrence data and detailed therapeutic methods are not provided. Even with these limitations, our study is the first to use a large public database cohort of KCC to investigate the characteristics of patients and tumors.

Conclusions
===========

KCC patients have worse survival compared to OCC patients. Older age, higher M stages, and higher pathology grades were associated with worse KCC patient survival.
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###### 

Baseline characteristics of KCC and OCC patients.

  Patient characteristics   Klatskin tumor (n=1341)   Other biliary tract malignancies (n=24796)   P value
  ------------------------- ------------------------- -------------------------------------------- ---------
  Year of diagnosis                                                                                \<0.001
   2000--2004               278 (20.7)                6992 (28.2)                                  
   2005--2009               424 (31.6)                7869 (31.7)                                  
   2010--2014               639 (47.7)                9935 (40.1)                                  
  Gender                                                                                           0.866
   Male                     687 (51.2)                12769 (51.5)                                 
   Female                   654 (48.8)                12027 (48.5)                                 
  Race                                                                                             \<0.001
   White                    1101 (82.1)               19285 (77.8)                                 
   Black                    217 (16.2)                1845 (7.4)                                   
   Other                    21 (1.6)                  3502 (14.1)                                  
   Unknown                  2 (0.2)                   64 (0.3)                                     
  Treatment                                                                                        \<0.001
   No surgery               984 (73.4)                16682 (67.3)                                 
   Surgical treatment       297 (22.1)                7512 (30.3)                                  
   Unknown                  60 (4.5)                  602 (2.4)                                    
  Age                                                                                              0.095
   Range                    19--01                    1--117                                       
   Median                   71.0                      70.0                                         
   Mean                     69.7                      69.1                                         
  Survival                                                                                         \<0.001
   Range                    0--119                    0--179                                       
   Median                   4                         6                                            
   Mean                     8.4                       16.8                                         

###### 

Baseline tumor characteristics of the KCC and OCC patients.

  Tumor characteristics   Klatskin tumor (n=1341)   Other biliary tract malignancies (n=24796)   P value
  ----------------------- ------------------------- -------------------------------------------- ---------
  Pathological grade                                                                             \<0.001
   G1                     53 (4.0)                  1538 (6.2)                                   
   G2                     227 (16.9)                5111 (20.6)                                  
   G3                     223 (16.6)                4006 (16.2)                                  
   G4                     14 (1.0)                  195 (0.8)                                    
   Gx                     824 (61.4)                13946 (56.2)                                 
  T stage                                                                                        0.040
   T0                     11 (0.8)                  165 (0.7)                                    
   T1                     223 (16.6)                4230 (17.1)                                  
   T2                     104 (7.8)                 2100 (8.5)                                   
   T3                     241 (18.0)                4149 (16.7)                                  
   T4                     177 (13.2)                2663 (10.7)                                  
   Tx                     585 (43.6)                11489 (46.3)                                 
  N stage                                                                                        \<0.001
   N0                     607 (45.3)                9921 (40.0)                                  
   N1                     277 (20.7)                4660 (18.8)                                  
   Nx                     457 (34.1)                10215 (41.2)                                 
  M stage                                                                                        \<0.001
   M0                     582 (43.4)                10810 (43.6)                                 
   M1                     368 (27.4)                5525 (22.3)                                  
   Mx                     391 (29.2)                8461 (34.1)                                  
  SEER historic stage                                                                            \<0.001
   Localized              277 (20.7)                4440 (17.9)                                  
   Regional               401 (29.9)                8827 (35.6)                                  
   Distant                447 (33.3)                7129 (28.8)                                  
   Unstaged               216 (16.1)                4400 (17.7)                                  
  Size                                                                                           0.225
   Median                 3.0                       3.0                                          
   Mean                   4.29                      4.05                                         
   Incidence              0.097                     2.526                                        
  APC                     −2.962 (P=0.001)          3.688 (P\<0.001)                             

###### 

Survival status stratified by AJCC 6^th^ stage.

                     Klatskin tumor   Other biliary tract malignancies                                     
  ------------------ ---------------- ---------------------------------- ----- ----- ------- ------ ------ ------
  All                1311             22.2                               3.4   0.5   24366   43.2   22.2   17.5
  6^th^ AJCC stage                                                                                         
   I                 207              26.1                               3.4   1     3636    64.0   44.8   38.7
   II                143              40.6                               9.1   0.7   3295    65.3   35.5   27.8
   III               163              31.3                               3.1   --    2622    54.4   23.0   16.7
   IV                367              11.7                               0.8   0.3   5514    21.7   4.8    2.3

###### 

Baseline characteristics of the patients in the matched cohort.

                        Klatskin tumor   Other biliary tract Malignancies   P value
  --------------------- ---------------- ---------------------------------- ---------
  Year of diagnosis                                                         0.990
   2000--2004           77               77                                 
   2005--2009           164              162                                
   2010--2014           282              284                                
  Gender                                                                    0.620
   Male                 253              245                                
   Female               270              278                                
  Race                                                                      0.875
   White                441              450                                
   Black                72               63                                 
   Other                9                9                                  
   Unknown              1                1                                  
  Treatment                                                                 0.194
   No surgery           302              285                                
   Surgical treatment   219              238                                
   Unknown              2                0                                  
  Pathological grade                                                        0.653
   G1                   18               13                                 
   G2                   132              141                                
   G3                   134              146                                
   G4                   6                4                                  
   Gx                   233              219                                
  TNM stage                                                                 0.981
   I                    78               76                                 
   II                   110              106                                
   III                  117              121                                
   IV                   124              120                                
   Unknown              94               100                                
  T stage                                                                   0.995
   T0                   8                8                                  
   T1                   98               94                                 
   T2                   76               74                                 
   T3                   149              153                                
   T4                   86               82                                 
   Tx                   106              112                                
  N stage                                                                   0.788
   N0                   254              243                                
   N1                   177              183                                
   Nx                   92               97                                 
  M stage                                                                   833
   M0                   317              314                                
   M1                   124              120                                
   Mx                   82               89                                 
  SEER historic stage                                                       0.996
  Localized             98               96                                 
   Regional             264              268                                
   Distant              142              140                                
   Unstaged             19               19                                 

###### 

Univariate and multivariate analysis of the effect of different factors on survival outcomes in KCC patients.

                               CSS                                               
  ---------------------------- ------------------- --------- ------------------- ---------
  Gender                                                                         
   Female                      Reference                                         
   Male                        1.01 (0.90--1.12)   0.900                         
  Year of diagnosis                                                              
   2000--2004                  Reference                                         
   2005--2009                  1.00 (0.85--1.16)   0.947                         
   2010--2014                                                                    
  Age at diagnosis                                                               
   ≤70 years                   Reference                     Reference           
   \>70 years                  1.33 (1.19--1.48)   \<0.001   1.33 (1.19--1.49)   \<0.001
  Race                                                                           
   White                       Reference                                         
   Black                       1.09 (0.94--1.27)   0.233                         
   Others                      1.11 (0.71--1.73)   0.650                         
   Unknown                     0.54 (0.13--2.14)   0.377                         
  Grade                                                                          
   Well differentiated         Reference                     Reference           
   Moderately differentiated   1.03 (0.77--1.40)   0.834     1.07 (0.79--1.45)   0.664
   Poorly differentiated       1.47 (1.09--1.99)   0.012     1.55 (1.14--2.10)   0.005
   Undifferentiated            1.39 (0.77--2.51)   0.277     1.40 (0.78--2.54)   0.259
   Unknown                     2.01 (1.51--2.66)   \<0.001   1.90 (1.43--2.52)   \<0.001
  T stage                                                                        
   T0                          Reference                                         
   T1                          0.94 (0.51--1.72)   0.835                         
   T2                          0.72 (0.39--1.35)   0.306                         
   T3                          1.02 (0.56--1.86)   0.956                         
   T4                          1.43 (0.78--2.62)   0.253                         
   Unknown                     1.19 (0.66--2.17)   0.566                         
  N stage                                                                        
   N0                          Reference                     Reference           
   N1                          0.80 (0.70--0.93)   0.002     0.88 (0.76--1.02)   0.090
   Unknown                     1.03 (0.91--1.17)   0.598     1.01 (0.80--1.28)   0.949
  M stage                                                                        
   M0                          Reference                     Reference           
   M1                          1.12 (1.05--1.19)   \<0.001   1.43 (1.24--1.64)   \<0.001
   Unknown                                                   1.07 (0.93--1.22)   0.332
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